The Nebraska State Racing Commission has served hearing notices to seven trainers of horses whose post-race samples tested positive for clonidine, a drug used in humans to treat high blood pressure. The commission released the names of the trainers Thursday as a matter of public record.
A human drug used to treat high blood pressure, Attention Deficit Hyperactivity Disorder, and addictive behavior has been detected in at least 10 post-race samples of horses racing in Nebraska recently, and sources say the number of positive tests could double in the coming weeks. Seven trainers have been notified by the Nebraska Racing Commission that their horses tested positive for Clonidine, which drug testing experts say can have both a calming and analgesic effect on horses and is closely related to Romifidine and Guanabenz, two drugs suspected by racing officials as being used illegally on horses.
Most Popular Stories
- Commentary: Permeating Speed is a Problem
- Bolo Thrives in Return to Turf at Santa Anita
- American Pharoah Schools, Back to Galloping
- Materiality, Frosted Drill Toward Belmont
- Zenyatta in Foal to War Front Again
- The Truth Or Else Joins Belmont Stakes Mix
- Son Wins 'Lopez Battle' at Golden Gate Fields
- Blood-Horse Unveils Multimedia Tablet Edition
- Bill Puts USADA in Charge of Drug Testing
- Smooth Stride Could Lift American Pharoah